a therapeutics company focusing on discovering and developing novel gene control therapies
Industry Biotechnology
A.I.dvisor indicates that over the last year, SYRS has been closely correlated with ABP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYRS jumps, then ABP could also see price increases.
Ticker / NAME | Correlation To SYRS | 1D Price Change % | ||
---|---|---|---|---|
SYRS | 100% | -4.91% | ||
ABP - SYRS | 70% Closely correlated | -3.91% | ||
XFOR - SYRS | 50% Loosely correlated | +14.53% | ||
CGEN - SYRS | 30% Poorly correlated | N/A | ||
SVRA - SYRS | 28% Poorly correlated | -1.23% | ||
IRD - SYRS | 28% Poorly correlated | -8.84% | ||
More |